Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q108605103 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000146.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q108605103 | ||
| 035 | ‡a (OCoLC)Q108605103 | ||
| 100 | 0 | ‡a Kenneth R. Brown ‡c American ivermectin researcher ‡9 en | |
| 670 | ‡a Author's Changes in the use profile of Mectizan: 1987–1997 | ||
| 670 | ‡a Author's Cross-resistance and imipenem. | ||
| 670 | ‡a Author's Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience. | ||
| 670 | ‡a Author's Imipenem-cilastatin in pediatric patients: an overview of safety and efficacy in studies conducted in the United States | ||
| 670 | ‡a Author's Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial. | ||
| 670 | ‡a Author's Imipenem/cilastatin treatment of lower extremity skin and soft tissue infections in diabetics | ||
| 670 | ‡a Author's Ivermectin--clinical trials and treatment schedules in onchocerciasis | ||
| 670 | ‡a Author's Ivermectin: effectiveness in lymphatic filariasis | ||
| 670 | ‡a Author's Problems and benefits of an antibiotic compassionate therapy program | ||
| 670 | ‡a Author's Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin | ||
| 670 | ‡a Author's Safety and tolerance comparison of imipenem-cilastatin to cephalothin and cefazolin | ||
| 670 | ‡a Author's Safety of Cefoxitin: An Approach to the Analysis of Laboratory Data | ||
| 670 | ‡a Author's The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans | ||
| 670 | ‡a Author's The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials | ||
| 670 | ‡a Author's The regulation of biological products | ||
| 670 | ‡a Author's The safety profile of imipenem/cilastatin: worldwide clinical experience based on 3470 patients | ||
| 919 | ‡a crossresistanceandimipenem ‡A Cross-resistance and imipenem. ‡9 1 | ||
| 919 | ‡a changesintheuseprofileofmectizan1987 ‡A Changes in the use profile of Mectizan: 1987–1997 ‡9 1 | ||
| 919 | ‡a efficacyandsafetyofimipenemcilastatinareviewofworldwideclinicalexperience ‡A Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience. ‡9 1 | ||
| 919 | ‡a imipenemcilastatininpediatricpatientsanoverviewofsafetyandefficacyinstudiesconductedintheunitedstates ‡A Imipenem-cilastatin in pediatric patients: an overview of safety and efficacy in studies conducted in the United States ‡9 1 | ||
| 919 | ‡a imipenemcilastatintherapyofseriousinfectionsausmulticenternoncomparativetrial ‡A Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial. ‡9 1 | ||
| 919 | ‡a imipenemcilastatintreatmentoflowerextremityskinandsofttissueinfectionsindiabetics ‡A Imipenem/cilastatin treatment of lower extremity skin and soft tissue infections in diabetics ‡9 1 | ||
| 919 | ‡a ivermectinclinicaltrialsandtreatmentschedulesinonchocerciasis ‡A Ivermectin--clinical trials and treatment schedules in onchocerciasis ‡9 1 | ||
| 919 | ‡a ivermectineffectivenessinlymphaticfilariasis ‡A Ivermectin: effectiveness in lymphatic filariasis ‡9 1 | ||
| 919 | ‡a problemsandbenefitsofanantibioticcompassionatetherapyprogram ‡A Problems and benefits of an antibiotic compassionate therapy program ‡9 1 | ||
| 919 | ‡a reviewofadverseexperiencesandtolerabilityinthe12516patientstreatedwithimipenemcilastatin ‡A Review of adverse experiences and tolerability in the first 2,516 patients treated with imipenem/cilastatin ‡9 1 | ||
| 919 | ‡a safetyandtolerancecomparisonofimipenemcilastatintocephalothinandcefazolin ‡A Safety and tolerance comparison of imipenem-cilastatin to cephalothin and cefazolin ‡9 1 | ||
| 919 | ‡a safetyofcefoxitinanapproachtotheanalysisoflaboratorydata ‡A Safety of Cefoxitin: An Approach to the Analysis of Laboratory Data ‡9 1 | ||
| 919 | ‡a antiparasiticmoxidectinsafetytolerabilityandpharmacokineticsinhumans ‡A The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans ‡9 1 | ||
| 919 | ‡a efficacyresultsandsafetyprofileofimipenemcilastatinfromtheclinicalresearchtrials ‡A The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials ‡9 1 | ||
| 919 | ‡a regulationofbiologicalproducts ‡A The regulation of biological products ‡9 1 | ||
| 919 | ‡a safetyprofileofimipenemcilastatinworldwideclinicalexperiencebasedon3470patients ‡A The safety profile of imipenem/cilastatin: worldwide clinical experience based on 3470 patients ‡9 1 | ||
| 943 | ‡a 199x ‡A 1997 ‡9 1 | ||
| 996 | ‡2 ISNI|0000000388302689 | ||
| 996 | ‡2 J9U|987007329575305171 | ||
| 996 | ‡2 LC|no2023042795 | ||
| 996 | ‡2 LC|n 81146998 | ||
| 996 | ‡2 LC|n 95014727 | ||
| 996 | ‡2 CAOONL|ncf11351331 | ||
| 996 | ‡2 SUDOC|226116174 | ||
| 996 | ‡2 BNCHL|10000000000000000211182 | ||
| 996 | ‡2 ISNI|0000000444296982 | ||
| 996 | ‡2 ISNI|0000000083972067 | ||
| 996 | ‡2 DNB|136633293 | ||
| 996 | ‡2 LC|n 81145264 | ||
| 996 | ‡2 ISNI|0000000382471051 | ||
| 996 | ‡2 SUDOC|079569110 | ||
| 996 | ‡2 DNB|1222927942 | ||
| 996 | ‡2 LC|n 99021758 | ||
| 996 | ‡2 DNB|1035328658 | ||
| 996 | ‡2 DNB|1063753457 | ||
| 996 | ‡2 BNE|XX961787 | ||
| 996 | ‡2 LC|no2016059829 | ||
| 996 | ‡2 ISNI|0000000047789214 | ||
| 996 | ‡2 LC|no2003114678 | ||
| 996 | ‡2 ISNI|0000000053866765 | ||
| 996 | ‡2 LC|n 85146020 | ||
| 996 | ‡2 ISNI|0000000039993098 | ||
| 996 | ‡2 LC|n 2007074897 | ||
| 996 | ‡2 RERO|A000169306 | ||
| 996 | ‡2 LC|no2016093249 | ||
| 996 | ‡2 LC|no2023055646 | ||
| 996 | ‡2 NLA|000035700108 | ||
| 996 | ‡2 RERO|A012311173 | ||
| 996 | ‡2 ISNI|0000000024984834 | ||
| 996 | ‡2 SUDOC|256277451 | ||
| 996 | ‡2 NUKAT|n 2021030759 | ||
| 996 | ‡2 DNB|1096205602 | ||
| 996 | ‡2 DNB|170061299 | ||
| 996 | ‡2 LC|n 80022267 | ||
| 996 | ‡2 LC|no2006083422 | ||
| 996 | ‡2 LC|no2006117253 | ||
| 996 | ‡2 B2Q|0000281306 | ||
| 996 | ‡2 LC|no2008173456 | ||
| 996 | ‡2 J9U|987007425110205171 | ||
| 996 | ‡2 BIBSYS|90717629 | ||
| 996 | ‡2 NTA|069082693 | ||
| 996 | ‡2 SUDOC|03490669X | ||
| 996 | ‡2 SUDOC|085962309 | ||
| 996 | ‡2 J9U|987007380951605171 | ||
| 996 | ‡2 DNB|135143888 | ||
| 996 | ‡2 SUDOC|191065145 | ||
| 996 | ‡2 LC|n 2016004392 | ||
| 996 | ‡2 NKC|mzk2003217157 | ||
| 996 | ‡2 NLA|000035665495 | ||
| 996 | ‡2 ISNI|0000000081987644 | ||
| 996 | ‡2 NUKAT|n 2006076827 | ||
| 996 | ‡2 J9U|987007597716105171 | ||
| 996 | ‡2 ISNI|0000000115778526 | ||
| 996 | ‡2 ISNI|0000000381524991 | ||
| 996 | ‡2 CAOONL|ncf12129167 | ||
| 996 | ‡2 LC|nr 92032719 | ||
| 996 | ‡2 BIBSYS|99044260 | ||
| 996 | ‡2 ISNI|0000000075336730 | ||
| 996 | ‡2 ISNI|0000000031305086 | ||
| 996 | ‡2 NII|DA05024913 | ||
| 996 | ‡2 ISNI|000000040914334X | ||
| 996 | ‡2 CAOONL|ncf10381592 | ||
| 996 | ‡2 NTA|405406312 | ||
| 996 | ‡2 NSK|000791272 | ||
| 996 | ‡2 N6I|vtls000010150 | ||
| 996 | ‡2 CAOONL|ncf10506000 | ||
| 996 | ‡2 ISNI|0000000037079534 | ||
| 996 | ‡2 RERO|A027538563 | ||
| 996 | ‡2 DNB|173202144 | ||
| 996 | ‡2 CAOONL|ncf10289904 | ||
| 996 | ‡2 SUDOC|188807314 | ||
| 996 | ‡2 LC|n 92114004 | ||
| 996 | ‡2 ISNI|0000000053493161 | ||
| 996 | ‡2 SUDOC|06866124X | ||
| 996 | ‡2 BNF|16650481 | ||
| 996 | ‡2 LC|n 78091967 | ||
| 996 | ‡2 LC|n 88120695 | ||
| 996 | ‡2 ISNI|0000000084058090 | ||
| 996 | ‡2 CAOONL|ncf10713251 | ||
| 996 | ‡2 CAOONL|ncf11178953 | ||
| 996 | ‡2 LC|n 88621994 | ||
| 996 | ‡2 ISNI|0000000384902839 | ||
| 996 | ‡2 BNF|12382168 | ||
| 996 | ‡2 CAOONL|ncf12046292 | ||
| 996 | ‡2 ISNI|0000000021718848 | ||
| 996 | ‡2 LC|nb2019021350 | ||
| 996 | ‡2 LC|nb2019021351 | ||
| 996 | ‡2 BNF|12560904 | ||
| 996 | ‡2 NTA|290673259 | ||
| 996 | ‡2 ISNI|0000000032160843 | ||
| 996 | ‡2 LC|no2014140726 | ||
| 996 | ‡2 N6I|vtls000088044 | ||
| 996 | ‡2 NLA|000035474592 | ||
| 996 | ‡2 RERO|A006370007 | ||
| 996 | ‡2 NTA|244452113 | ||
| 996 | ‡2 ISNI|0000000400150789 | ||
| 996 | ‡2 ISNI|0000000051637803 | ||
| 996 | ‡2 RERO|A003048350 | ||
| 996 | ‡2 LC|n 81103845 | ||
| 996 | ‡2 LC|n 98046293 | ||
| 996 | ‡2 BNF|12178387 | ||
| 996 | ‡2 ISNI|0000000121423115 | ||
| 996 | ‡2 J9U|987007457136805171 | ||
| 996 | ‡2 RERO|A003048352 | ||
| 996 | ‡2 SUDOC|120838338 | ||
| 996 | ‡2 B2Q|0000938896 | ||
| 996 | ‡2 ISNI|0000000038175018 | ||
| 996 | ‡2 W2Z|1061390 | ||
| 996 | ‡2 RERO|A003048344 | ||
| 996 | ‡2 LC|nb2007018182 | ||
| 996 | ‡2 RERO|A003048342 | ||
| 996 | ‡2 BNF|14479431 | ||
| 996 | ‡2 NUKAT|n 2016180489 | ||
| 996 | ‡2 LC|n 2009058024 | ||
| 996 | ‡2 RERO|A003048349 | ||
| 996 | ‡2 DNB|128173408X | ||
| 996 | ‡2 SUDOC|068984634 | ||
| 996 | ‡2 SUDOC|186292171 | ||
| 996 | ‡2 DNB|1059835835 | ||
| 996 | ‡2 PLWABN|9810607731205606 | ||
| 996 | ‡2 SUDOC|259283746 | ||
| 996 | ‡2 ISNI|0000000107786868 | ||
| 996 | ‡2 LC|no2001054608 | ||
| 996 | ‡2 LC|n 80017482 | ||
| 996 | ‡2 LC|n 84016959 | ||
| 996 | ‡2 LC|n 90691514 | ||
| 996 | ‡2 SUDOC|24303167X | ||
| 996 | ‡2 LC|n 80042144 | ||
| 996 | ‡2 LC|n 90714679 | ||
| 996 | ‡2 BIBSYS|90643733 | ||
| 996 | ‡2 ISNI|0000000034075685 | ||
| 996 | ‡2 LC|nb2007022318 | ||
| 996 | ‡2 DNB|1158141335 | ||
| 996 | ‡2 ISNI|0000000021628519 | ||
| 996 | ‡2 NUKAT|n 2021162342 | ||
| 996 | ‡2 ISNI|0000000430401905 | ||
| 996 | ‡2 SUDOC|162456891 | ||
| 996 | ‡2 NSK|000269825 | ||
| 996 | ‡2 CAOONL|ncf11241610 | ||
| 996 | ‡2 J9U|987007274753605171 | ||
| 996 | ‡2 NUKAT|n 98013326 | ||
| 996 | ‡2 LC|n 81134126 | ||
| 996 | ‡2 LC|n 87857733 | ||
| 996 | ‡2 BIBSYS|1061390 | ||
| 996 | ‡2 BIBSYS|90176647 | ||
| 996 | ‡2 RERO|A012898537 | ||
| 996 | ‡2 BNF|13495765 | ||
| 996 | ‡2 SUDOC|186328745 | ||
| 996 | ‡2 ISNI|0000000455429162 | ||
| 996 | ‡2 LC|n 2008033172 | ||
| 996 | ‡2 DNB|171808401 | ||
| 996 | ‡2 CAOONL|ncf11479739 | ||
| 996 | ‡2 NSK|000477309 | ||
| 996 | ‡2 ISNI|000000010205983X | ||
| 996 | ‡2 NTA|070403139 | ||
| 996 | ‡2 ISNI|000000007747773X | ||
| 996 | ‡2 DNB|1096205726 | ||
| 996 | ‡2 CAOONL|ncf10633014 | ||
| 996 | ‡2 ISNI|0000000451355653 | ||
| 996 | ‡2 NKC|xx0091713 | ||
| 996 | ‡2 LC|no2013002599 | ||
| 996 | ‡2 ISNI|0000000035638742 | ||
| 996 | ‡2 BIBSYS|90691674 | ||
| 996 | ‡2 RERO|A012466797 | ||
| 996 | ‡2 LC|n 97022300 | ||
| 996 | ‡2 BNF|17035034 | ||
| 996 | ‡2 J9U|987007423004005171 | ||
| 996 | ‡2 CAOONL|ncf10807665 | ||
| 996 | ‡2 LC|n 2007052773 | ||
| 996 | ‡2 ISNI|0000000048164881 | ||
| 996 | ‡2 LC|n 2001090023 | ||
| 996 | ‡2 SUDOC|185829503 | ||
| 996 | ‡2 ISNI|000000002978177X | ||
| 996 | ‡2 CAOONL|ncf10146714 | ||
| 996 | ‡2 CAOONL|ncf10463846 | ||
| 996 | ‡2 LC|n 84101901 | ||
| 996 | ‡2 LC|no2008132659 | ||
| 996 | ‡2 NTA|292213948 | ||
| 996 | ‡2 BNC|981058516360306706 | ||
| 996 | ‡2 ISNI|0000000111509775 | ||
| 996 | ‡2 NUKAT|n 2016168042 | ||
| 996 | ‡2 ISNI|0000000355159820 | ||
| 996 | ‡2 DNB|141992573 | ||
| 996 | ‡2 SUDOC|129210145 | ||
| 996 | ‡2 J9U|987007340618805171 | ||
| 996 | ‡2 LC|nb2022001842 | ||
| 996 | ‡2 NII|DA01818664 | ||
| 996 | ‡2 NTA|069852995 | ||
| 996 | ‡2 LC|n 77010595 | ||
| 996 | ‡2 ISNI|0000000382156764 | ||
| 996 | ‡2 LC|n 77020100 | ||
| 996 | ‡2 LC|no2019145125 | ||
| 996 | ‡2 ISNI|0000000030614207 | ||
| 996 | ‡2 BNF|14671249 | ||
| 996 | ‡2 ISNI|0000000023739458 | ||
| 996 | ‡2 ISNI|0000000023680177 | ||
| 996 | ‡2 BNF|17069606 | ||
| 996 | ‡2 ISNI|0000000110505107 | ||
| 996 | ‡2 NII|DA01907902 | ||
| 996 | ‡2 PTBNP|269587 | ||
| 996 | ‡2 ISNI|0000000039444769 | ||
| 996 | ‡2 NII|DA19497039 | ||
| 996 | ‡2 LC|no2016005653 | ||
| 996 | ‡2 BNC|981058516366406706 | ||
| 996 | ‡2 DNB|135703557 | ||
| 996 | ‡2 DNB|171432800 | ||
| 996 | ‡2 LC|no 95060518 | ||
| 996 | ‡2 ISNI|0000000028638138 | ||
| 996 | ‡2 LC|no 94022647 | ||
| 996 | ‡2 NTA|074208942 | ||
| 996 | ‡2 SUDOC|257794298 | ||
| 996 | ‡2 BIBSYS|2086801 | ||
| 996 | ‡2 ISNI|0000000081252154 | ||
| 996 | ‡2 CAOONL|ncf11349126 | ||
| 996 | ‡2 LC|n 84167095 | ||
| 996 | ‡2 NSK|000193435 | ||
| 996 | ‡2 BNF|12491396 | ||
| 996 | ‡2 RERO|A012334043 | ||
| 996 | ‡2 NTA|169180107 | ||
| 996 | ‡2 LC|n 78022295 | ||
| 996 | ‡2 DNB|1151541389 | ||
| 996 | ‡2 LC|n 84216216 | ||
| 996 | ‡2 LC|no 00013864 | ||
| 996 | ‡2 BIBSYS|90336481 | ||
| 996 | ‡2 LC|n 90668342 | ||
| 996 | ‡2 ISNI|0000000443725845 | ||
| 996 | ‡2 SUDOC|170300897 | ||
| 996 | ‡2 LC|n 80066970 | ||
| 996 | ‡2 LC|n 79011869 | ||
| 996 | ‡2 BNE|XX1079565 | ||
| 996 | ‡2 ISNI|0000000079002447 | ||
| 996 | ‡2 DNB|1235323919 | ||
| 996 | ‡2 NTA|307930807 | ||
| 996 | ‡2 DNB|105629809X | ||
| 996 | ‡2 CAOONL|ncf10238617 | ||
| 996 | ‡2 SUDOC|267562594 | ||
| 996 | ‡2 RERO|A003048353 | ||
| 996 | ‡2 DNB|1146984065 | ||
| 996 | ‡2 ISNI|0000000029127890 | ||
| 996 | ‡2 ISNI|0000000452986289 | ||
| 996 | ‡2 LC|n 93122000 | ||
| 996 | ‡2 LC|nb2006004959 | ||
| 996 | ‡2 NTA|235069957 | ||
| 996 | ‡2 ISNI|0000000071060722 | ||
| 996 | ‡2 ISNI|0000000082795871 | ||
| 996 | ‡2 RERO|A003048343 | ||
| 996 | ‡2 JPG|500269093 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
